Deutsches Krebsforschungszentrum (DKFZ)

Research facility


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000404920584

ROR: https://ror.org/04cdgtt98

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects (2020) Jansen L, Merz M, Engelhardt M, Weisel K, Scheid C, Straka C, Langer C, et al. Journal article A Federated Online Search Tool for Biospecimens (Sample Locator): Usability Study (2020) Schüttler C, Huth V, von Jagwitz-Biegnitz M, Lablans M, Prokosch HU, Griebel L Journal article Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model (2020) Ellmann S, Seyler L, Gillmann C, Popp V, Treutlein C, Bozec A, Uder M, Bäuerle T Journal article Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma (2020) Busch E, Kreutzfeldt S, Agaimy A, Mechtersheimer G, Horak P, Brors B, Hutter B, et al. Journal article Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- And diffusion-weighted MRI (2020) Bostel T, Dreher C, Wollschläger D, Mayer A, König F, Bickelhaupt S, Schlemmer HP, et al. Journal article Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium (2020) Sanchez-Maldonado JM, Campa D, Springer J, Badiola J, Niazi Y, Moniz-Diez A, Hernandez-Mohedo F, et al. Journal article DETECT III und IV - Individualisierte CTC-basierte Therapie des HER2-negativen metastasierten Mammakarzinoms (2020) Friedl TWP, Schneeweiss A, Mueller , Riethdorf S, Pantel K, Taran FA, Polasik A, et al. Conference contribution DETECT V/CHEVENDO - duale HER2-zielgerichteten Therapie mit Trastuzumab und Pertuzumab plus Ribociclib in Kombination mit Chemotherapie oder endokriner Therapie bei Patientinnen mit HER2-positivem und hormonrezeptor-positivem metastasierten Mammakarzinom (2020) Friedl TWP, Polasik A, Tzschaschel M, Schochter F, De Gregorio A, Fasching P, Taran FA, et al. Conference contribution Quantitative susceptibility mapping depicts severe myelin deficit and iron deposition in a transgenic model of multiple system atrophy (2020) Lambrecht V, Hanspach J, Hoffmann A, Seyler L, Mennecke A, Straub S, Marxreiter F, et al. Journal article Sodium relaxometry using 23 Na MR fingerprinting: A proof of concept (2020) Kratzer FJ, Flassbeck S, Nagel AM, Behl NG, Knowles BR, Bachert P, Ladd ME, Schmitter S Journal article